Merck & Co. logo

Merck & Co. MRK

$ 121.42 -1.02%

Annual report 2025
added 02-24-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

2.5 B

Market Cap[1]

$ 304 B

EBITDA (LTM)

$ 2.86 B

P/E (LTM)

16.71

P/S (LTM)

4.7

EPS (LTM)

7.34

Merck & Co., Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and distribution of innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has grown to become one of the largest pharmaceutical companies in the world, with operations in over 140 countries.

The company's mission is to improve the health and well-being of people and animals around the world. Merck is committed to discovering new treatments and cures for some of the most challenging diseases, including cancer, Alzheimer's disease, and HIV/AIDS. The company has a strong pipeline of products in development, with a focus on immunotherapy and oncology.

Merck is also a leader in the development and distribution of vaccines. The company has played a key role in the fight against infectious diseases such as measles, mumps, rubella, and HPV. Merck's vaccines have saved countless lives around the world and continue to be an important tool in preventing disease outbreaks.

In addition to its pharmaceutical and vaccine business, Merck also has a thriving animal health division. The company develops and manufactures products for livestock, pets, and wildlife. Merck's animal health products are used to prevent and treat diseases in animals, improving their health and welfare.

Merck is committed to operating responsibly and sustainably. The company has set ambitious goals to reduce its environmental impact, improve the health and safety of its employees, and support the communities where it operates. Merck has been recognized for its sustainability efforts, including being named to the Dow Jones Sustainability Index for the past 16 years.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Nanobiotix S.A. Nanobiotix S.A.
NBTX
$ 30.34 -0.82 % $ 286 B Nasdaq Global Select Market franceFrance
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 1.4 -0.71 % $ 360 M Nasdaq Global Market usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 95.5 3.83 % $ 27.2 B Nasdaq Global Select Market germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 2.92 -0.34 % $ 6.35 B NYSE American israelIsrael
Aytu BioScience Aytu BioScience
AYTU
$ 2.55 -0.78 % $ 16 M Nasdaq Capital Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B Nasdaq Global Select Market britainBritain
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 20.37 -2.4 % $ 952 M Nasdaq Global Select Market usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 4.08 -2.16 % $ 436 M Nasdaq Global Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 24.21 -1.47 % $ 3.08 B Nasdaq Global Select Market,SPB usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 32.24 -4.1 % $ 2.14 B Nasdaq Global Select Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 3.13 -1.26 % $ 315 M Nasdaq Global Select Market usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
- -55.98 % $ 2.15 M Nasdaq Global Market usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Avid Bioservices Avid Bioservices
CDMO
- - $ 789 M Nasdaq Capital Market usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
- - $ 1.41 B Nasdaq Global Market usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
$ 1.0 -2.91 % $ 152 M Nasdaq Global Select Market germanyGermany
Immutep Limited Immutep Limited
IMMP
$ 0.31 -2.52 % $ 1.08 B Nasdaq Global Market australiaAustralia
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
- - $ 401 M Nasdaq Global Market usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
$ 3.83 -2.3 % $ 258 B Nasdaq Capital Market britainBritain
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Celsion Corporation Celsion Corporation
CLSN
- -6.63 % $ 13.9 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.